Aeternum Health (AETN) Return on Sales (2010 - 2026)

Aeternum Health (AETN) has 13 years of Return on Sales data on file, last reported at 0.62% in Q1 2026.

• On a quarterly basis, Return on Sales fell 62.0% year-over-year to 0.62% in Q1 2026; TTM through Mar 2026 was 0.12%, a 10.0% decrease from a year earlier, with the FY2025 full-year figure at 0.05%, up 11.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.62%, down from 0.04% in the prior quarter.
• Over the last five years, Return on Sales for AETN reached as high as 0.02% in Q1 2023 and fell as low as 1.75% in Q2 2023.
• Historically, Return on Sales has averaged 0.34% across 5 years, with a median of 0.15% in 2024.
• Across the five-year window, Return on Sales sank 156 bps in 2023 and rose 11 bps in 2025, its largest moves.
• Year by year, Return on Sales stood at 0.26% in 2022, then slumped by 40 bps to 0.36% in 2023, then jumped by 58 bps to 0.15% in 2024, then soared by 73 bps to 0.04% in 2025, then tumbled by 1365 bps to 0.62% in 2026.
• Per Business Quant data, the three most recent Return on Sales figures were 0.62% in Q1 2026, 0.04% in Q4 2025, and 0.17% in Q3 2025.